ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,051.09
0.00%
US Tech 100
21,191.60
0.62%
Dow Jones
43,828.06
-0.20%
Brent Oil
74.135
0.00%
Bitcoin
101,889.92
0.43%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Hofseth Biocare Asa (0Q6H)

  7. Hofseth Biocare Asa (0Q6H) News

0Q6H

Hofseth Biocare Asa (0Q6H)

Hofseth Biocare Asa
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0Q6H
DateTimeSourceHeadlineSymbolCompany
12/12/20249:07AMUK RegulatoryHofseth Biocare ASA: PRIMARY INSIDER NOTIFICATIONLSE:0Q6HHofseth Biocare Asa
12/05/20243:00AMUK RegulatoryHofseth Biocare ASA: Commences the project for a second hydrolysis plant in Norway to triple capacityLSE:0Q6HHofseth Biocare Asa
11/08/20242:15AMUK RegulatoryHofseth Biocare ASA: THIRD QUARTER 2024 FINANCIAL REPORTLSE:0Q6HHofseth Biocare Asa
10/22/20244:55AMUK RegulatoryHofseth Biocare ASA: CFO RESIGNATIONLSE:0Q6HHofseth Biocare Asa
10/08/20242:45AMUK RegulatoryHofseth Biocare ASA: HBC IMMUNOLOGY COMPLETES IN VIVO DRUG LEAD STUDIES FOR PROSTATE CANCER TREATMENTLSE:0Q6HHofseth Biocare Asa
08/23/20242:00AMUK RegulatoryHofseth Biocare ASA: SECOND QUARTER AND HALF YEAR 2024 FINANCIAL REPORTLSE:0Q6HHofseth Biocare Asa
08/14/20247:09AMUK RegulatoryHofseth Biocare ASA: GROUNDBREAKING STUDY REVEALS HOFSETH BIOCARE’S FULL SPECTRUM OMEGAS OMEGO SUPPORTS COVID-19 RECOVERYLSE:0Q6HHofseth Biocare Asa
07/02/20243:00AMUK RegulatoryHofseth Biocare ASA: HBC discovers new drug candidate for asthma and transfers it to HBC Immunology Inc.LSE:0Q6HHofseth Biocare Asa
06/11/20243:00AMUK RegulatoryHofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHYLSE:0Q6HHofseth Biocare Asa
05/16/20242:00AMUK RegulatoryHofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORTLSE:0Q6HHofseth Biocare Asa
05/10/20248:30AMUK RegulatoryHofseth Biocare ASA: Annual General Meeting completedLSE:0Q6HHofseth Biocare Asa
04/19/20247:00AMUK RegulatoryHofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2024LSE:0Q6HHofseth Biocare Asa
04/19/20242:00AMUK RegulatoryHofseth Biocare ASA: HBC ANNUAL REPORT 2023LSE:0Q6HHofseth Biocare Asa
04/05/202412:08PMUK RegulatoryHofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDINGLSE:0Q6HHofseth Biocare Asa
03/21/20245:40AMUK RegulatoryHofseth Biocare ASA: UPDATED COMPANY PRESENTATIONLSE:0Q6HHofseth Biocare Asa
03/14/20247:12AMUK RegulatoryHofseth Biocare ASA: CHAIR KRISTIN FJELLBY GRUNG STEPS DOWNLSE:0Q6HHofseth Biocare Asa
02/09/20242:00AMUK RegulatoryHofseth Biocare ASA: FOURTH QUARTER 2023 AND FULL YEAR FINANCIAL REPORTLSE:0Q6HHofseth Biocare Asa
02/06/20249:56AMUK RegulatoryHofseth Biocare ASA: HBC Immunology Inc successfully completes first animal model of prostate cancer with FT-005 in combination with hormonal (anti-androgen) therapy demonstrating significant anti-tumour activityLSE:0Q6HHofseth Biocare Asa
 Showing the most relevant articles for your search:LSE:0Q6H

Your Recent History

BOV
PTNT4M
PETTENATI PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved